Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine vs Midazolam for Pediatric Laceration Repair
NCT02168439Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Jun 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in anxiety disorder (2 arms), sponsored by University of Pittsburgh. Primary endpoint: Modified Yale Preoperative Anxiety Scale at Day 1. Started Jun 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT02168439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02168439.